Leibniz Research Alliances
Leibniz Research Alliance Healthy Aging
Environmentally-induced aging processes are a central focus of the IUF’s mission. Therefore, the institute contributes through various research activities from several working groups to the Leibniz Research Alliance Healthy Aging. The IUF participates in the project "DNA damage responses in aging" together with three partner institutes of the alliance (Leibniz Institute on Aging – Fritz Lipmann Institute (FLI), Leibniz Institute for Molecular Pharmacology (FMP) and Leibniz Institute for Neurobiology (LIN)). This project is supported by funding from the Leibniz Competition. Prof. Dr. Jean Krutmann is together with Prof. Dr. K. L. Rudolph from the FLI speaker of the Leibniz Research Alliance Healthy Aging.
To the Leibniz Research Alliance Healthy Aging
Leibniz Research Alliance Nanosafety
This alliance addresses questions regarding the safety of modern nanoparticles in the fields of medicine, material sciences and knowledge transfer. The extensive expertise of several working groups at the IUF on the effects of particulate materials on human provides a structural contribution to the success of the research alliance. The active cooperation of partners in this alliance is promoted by implementing a Leibniz promotion project that is supported by the IUF and the INM – Leibniz Institute for New Materialis in Saarbrücken.
To the Leibniz Research Alliance Nanosafety
Leibniz Research Alliance Bioactive Compounds and Biotechnology
The molecular prevention of environmentally-induced health disorders is a main focus in the research mission of the IUF and can be accomplished by the use of new bioactive compounds. The IUF has significantly contributed to the development of preventive strategies against environmental influences. Thus, active substances based on compatible solutes were developed in the IUF and were brought to human use. These expertise and experiences are the contribution of the IUF to the Leibniz Research Alliance Bioactive Compounds and Biotechnology.
To the Leibniz Research Alliance Bioactive Compounds and Biotechnology